Vorinostat approved in Japan for treatment of cutaneous T-cell lymphomas: status and prospects.

OncoTargets and Therapy
Akinori Sato

Abstract

Histone acetylation and deacetylation play important roles in the regulation of gene transcription and in the modulation of chromatin structure. The levels of histone acetylation are determined by the activities of histone acetyltransferases and histone deacetylases (HDACs). HDACs are associated with a number of oncogenes and tumor suppressor genes and can be aberrantly expressed and/or inappropriately activated in cancer cells. HDAC inhibitors have therefore recently emerged as a novel treatment modality against malignancies. They regulate gene expression by enhancing the acetylation of not only histones but also nonhistone proteins, including transcription factors, transcription regulators, signal transduction mediators, and DNA repair enzymes, and they inhibit cancer growth. Vorinostat (suberoylanilide hydroxamic acid) is one of the most potent HDAC inhibitors, and was approved in Japan in 2011 for the treatment of cutaneous T-cell lymphoma. Numerous clinical trials have shown it to be effective against cutaneous T-cell lymphoma but less so against other types of cancer. Because vorinostat can overcome resistance to or enhance the efficacy of other anticancer agents, such as 5-fluorouracil, carboplatin, paclitaxel, bortezomi...Continue Reading

References

Oct 25, 1994·Proceedings of the National Academy of Sciences of the United States of America·P A MarksR A Rifkind
Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A ArcangeliM Olivotto
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·V M RichonP A Marks
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·V M RichonP A Marks
May 29, 2000·Journal of Cellular Physiology·W D Cress, E Seto
Aug 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·V M RichonP A Marks
Jul 5, 2001·Cellular and Molecular Life Sciences : CMLS·S TimmermannA Harel-Bellan
Dec 26, 2001·Japanese Journal of Cancer Research : Gann·J H ChoiD Y Kim
Mar 21, 2002·Nature Reviews. Cancer·P MarksW K Kelly
May 25, 2002·Nature·Charlotte HubbertTso-Pang Yao
Dec 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Constantine S MitsiadesKenneth C Anderson
Jan 22, 2004·Proceedings of the National Academy of Sciences of the United States of America·C-Y GuiP A Marks
Mar 26, 2004·The Prostate·Kalipso HalkidouCraig N Robson
May 18, 2004·Cancer Cell·Ping ZhuMartin Göttlicher
Jun 11, 2004·Annual Review of Biochemistry·Gil Blander, Leonard Guarente
Apr 27, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Qin C RyanEdward A Sausville
May 4, 2005·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Jaehwi SongSuk Woo Nam
May 18, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William Kevin KellyVictoria M Richon
Aug 27, 2005·Current Opinion in Chemical Biology·John M Denu
Sep 21, 2005·Breast Cancer Research and Treatment·Zhenhuan ZhangHirotaka Iwase
Nov 18, 2005·Gene·Michele A GlozakEdward Seto
Nov 26, 2005·Expert Opinion on Investigational Drugs·Paul A Marks, Milos Dokmanovic
Feb 18, 2006·Nature Reviews. Drug Discovery·Christine B Yoo, Peter A Jones
Jul 25, 2006·Clinical Genitourinary Cancer·Walter M StadlerJohn A Thompson
Aug 11, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Francis GilesKapil Bhalla
Feb 10, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dong YinH Phillip Koeffler
Mar 14, 2007·Apoptosis : an International Journal on Programmed Cell Death·S EmanueleG Tesoriere
May 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Suresh S RamalingamChandra P Belani
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elise A OlsenMadeleine Duvic
Jan 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David S SchrumpSeth M Steinberg

❮ Previous
Next ❯

Citations

Nov 2, 2019·Cancer Science·Kazuki OkuboAkinori Sato

❮ Previous
Next ❯

Methods Mentioned

BETA
acetylation
histone acetylation
ubiquitination

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.